BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | US

Overview

Corporate Details

ISIN(s):: US09061G1013
LEI:
Country:: United States of America
Address:: 105 DIGITAL DRIVE, 94949 NOVATO
Website:: https://www.biomarin.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PTC THERAPEUTICS, INC. Develops and commercializes pioneering medicines for patients with rare diseases.	United States of America	PTCT
Pulmatrix, Inc. Develops inhaled therapies for respiratory and CNS disorders using its iSPERSE™ technology.	United States of America	PULM
PUMA BIOTECHNOLOGY, INC. Develops and commercializes innovative cancer therapeutics, with an approved drug and a clinical pipeline.	United States of America	PBYI
Pure Biologics S.A. Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.	Poland	PUR
PureTech Health plc A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.	United States of America	PRTC
PURPLE BIOTECH LTD. Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.	United States of America	PPBT
Pyxis Oncology, Inc. Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.	United States of America	PYXS
PZ Cormay S.A. Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.	Poland	CRM
Q32 Bio Inc. Clinical-stage biotech developing biologic therapies for autoimmune and inflammatory diseases.	United States of America	QTTB
Quantum Biopharma Ltd. Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.	United States of America	QNTM